Trials / Conditions / Acute Myeloid Leukemia With Multilineage Dysplasia
Acute Myeloid Leukemia With Multilineage Dysplasia
6 registered clinical trials studyying Acute Myeloid Leukemia With Multilineage Dysplasia — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Biocollection in MyeloDysplastic Syndrome (P-MDS) NCT04869683 | University Hospital, Brest | N/A |
| Active Not Recruiting | Comparing the Addition of an Anti-Cancer Drug, Pomalidomide, to the Usual Chemotherapy Treatment (Daunorubicin NCT04802161 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Glutaminase Inhibitor CB-839 and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndrome NCT03047993 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |
| Completed | Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid Leukemia NCT02658487 | Vanderbilt-Ingram Cancer Center | Phase 2 |
| Completed | Tosedostat in Combination With Cytarabine or Decitabine in Treating Patients With Newly Diagnosed Acute Myeloi NCT01567059 | Fred Hutchinson Cancer Center | Phase 2 |
| Terminated | Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies NCT01028716 | Fred Hutchinson Cancer Center | Phase 2 |